origin
scientifi
c
strategi
behind
vaccinolog
histor
isol
inactiv
inject
fi
rst
invok
loui
pasteur
recombin
dna
nanotechnolog
much
enlarg
repertoir
vaccin
today
base
three
adjust
principl
attenu
inactiv
recombin
shown
fig
three
principl
regard
equal
experiment
possibl
new
vaccin
develop
pathogen
studi
detail
recombin
dna
nanotechnolog
chang
basic
scientifi
c
strategi
live
nonliv
vaccin
live
vaccin
nonadjuv
nonliv
vaccin
gener
adjuv
new
develop
tuberculosi
tb
highlight
broad
experiment
approach
today
estim
onethird
world
popul
infect
tb
bacillu
approxim
million
peopl
infect
everi
year
million
develop
diseas
million
die
curabl
diseas
tb
bacillu
kill
peopl
infecti
agent
alon
current
bcg
bacillu
vaccin
recommend
three
billion
dose
administ
sinc
introduct
bcg
prepar
strain
attenu
live
bovin
tuberculosi
bacillu
mycobacterium
bovi
lost
virul
human
special
subcultur
artifi
cial
medium
howev
although
protect
newborn
children
sever
form
tb
effi
caci
pulmonari
tb
adolesc
adult
far
optim
protect
rate
vari
accord
geograph
area
content
live
nonliv
vaccin
new
vaccin
vaccin
strategi
develop
includ
use
attenu
live
mycobacteria
recombin
microorgan
subunit
primeboost
strategi
base
success
administr
certain
mycobacteri
antigen
two
differ
vaccin
vector
dna
vaccin
variou
type
vaccin
differ
elicit
immun
respons
live
attenu
vaccin
lav
mimic
natur
infect
without
virul
trigger
activ
innat
immun
system
pamp
follow
inject
lav
rapidli
dissemin
throughout
vascular
network
drain
lymph
node
therefor
rout
applic
lav
specifi
calli
infl
uenc
immun
respons
lav
also
nt
need
adjuv
possess
natur
intrins
adjuv
safeti
concern
exist
replic
compet
possibl
recombin
wild
type
nonliv
vaccin
inactiv
recombin
vaccin
whether
contain
protein
carbohydr
less
effect
absenc
replic
vaccineinduc
immun
reaction
remain
limit
therefor
rout
vaccin
infl
uenc
effi
caci
durat
immun
reaction
nonliv
vaccin
induc
lower
antibodi
respons
gener
cytotox
lymphocyt
activ
compar
lav
nonliv
vaccin
regard
biolog
safe
fig
dna
vaccin
entail
direct
situ
inocul
dnabas
eukaryot
express
vector
encod
sequenc
pathogen
protein
antigen
construct
plasmid
subsequ
grown
bacteria
like
e
coli
highli
purifi
ed
via
chromatograph
method
lp
contamin
plasmid
prevent
immunotox
properti
natur
lp
purifi
cation
circular
doublestrand
dna
plasmid
readi
vaccin
de
novo
product
encod
antigen
host
result
elicit
antibodi
cellular
respons
activ
cytotox
lymphocyt
ctl
vaccin
protein
made
host
natur
protein
contain
import
posttransl
modifi
cation
correct
glycosyl
like
subunit
vaccin
dna
vaccin
must
adjuv
nake
dna
work
uniqu
advantag
dna
vaccin
abil
mimic
effect
live
attenu
vaccin
without
risk
associ
administr
infecti
albeit
attenu
materi
dna
vaccin
abl
stimul
complet
humor
cellular
immun
respons
peptid
fragment
process
via
endogen
pathway
result
present
antigen
cell
surfac
mhc
class
molecul
plasmid
dna
stabl
also
beyond
cold
chain
therefor
storag
transport
distribut
dna
vaccin
practic
also
cheaper
mostli
plasmid
dna
construct
fig
use
vaccin
share
fi
main
characterist
strong
promoterenhanc
sequenc
drive
incorpor
foreign
gene
conveni
clone
site
insert
foreign
gene
origin
replic
initi
plasmid
replic
polyadenylationtermin
sequenc
product
matur
mrna
resistanceantibiot
marker
select
immunomodul
eg
cpg
interleukin
ubiquitin
etc
plasmid
extra
plasmid
uptak
plasmid
dna
biolog
barrier
overcom
dna
vaccin
way
cell
nucleu
plasmid
dna
translat
cellular
mrna
deliveri
plasmid
dna
target
tissu
eg
skelet
muscl
skin
lot
tissu
nucleas
attack
dna
vaccin
degrad
larg
amount
applic
dna
also
extracellular
matrix
collagen
hyaluron
acid
infl
uenc
passag
applic
site
cell
membran
small
portion
estim
still
intact
plasmid
dna
cross
cell
membran
phagocytosi
pinocytosi
insid
cell
rout
toward
nucleu
also
spike
exoand
endonucleas
probabl
estim
success
activ
transport
nucleu
pore
membran
npc
small
particl
kda
abl
pass
nuclear
pore
complex
npc
passiv
diffus
larger
particl
need
support
carrier
protein
effi
cient
passag
complex
enorm
loss
plasmid
dna
variou
tool
develop
protect
plasmid
dna
thu
increas
effi
caci
encapsul
liposom
bind
dna
dendrim
figur
illustr
passag
plasmid
dna
extracellular
matrix
ecm
nucleu
wherea
human
medicin
clinic
trial
dna
vaccin
still
ongo
without
regist
product
market
fi
rst
approv
dna
vaccin
veterinarian
medicin
avail
sinc
discuss
fi
rst
veterinarian
dna
vaccin
develop
hors
davi
bs
wnv
gies
eav
today
number
current
clinic
trial
worldwid
veterinari
dna
vaccin
unmanag
probabl
speci
hit
canin
malign
melanoma
cmm
typic
begin
mouth
around
toe
spread
within
bodi
heart
lung
intestin
organ
canin
malign
melanoma
known
one
aggress
cancer
dog
deadli
cmm
commonli
seen
golden
retriev
scottish
terrier
dachshund
labrador
poodl
fig
metastas
tumor
found
often
distant
part
bodi
overal
biolog
cmm
similar
biolog
human
melanoma
howev
melanoma
dog
divers
biolog
behavior
due
race
varieti
factor
standard
treatment
surgeri
radiat
chemotherapi
common
tool
fi
ght
canin
malign
melanoma
tradit
tool
afford
minim
modest
stagedepend
clinic
benefi
ts
xenogen
dna
vaccin
plasmid
dna
contain
cdna
human
tyrosinas
hutyr
tumor
antigen
ta
nonmut
differenti
antigen
specifi
c
melanoma
tyrosinas
glycoprotein
essenti
process
melanin
synthesi
fig
like
ta
tyrosinas
overexpress
tumor
cell
therefor
ideal
target
cancer
therapi
normal
strong
immun
reaction
bodi
protein
immun
dog
xenogen
hutyr
cdna
break
immun
toler
self
tumor
differenti
antigen
induc
antibodi
cytotox
cell
respons
melanoma
cell
tyrosinas
highli
conserv
dog
mous
man
radiotherapi
case
posit
surgic
margin
posit
region
lymph
node
one
dose
contain
dna
given
volum
ml
transderm
rout
via
needlefre
vaccin
devic
booster
immun
given
interv
march
drug
manufactur
receiv
condit
licens
oncept
usda
full
licens
result
xenogen
immun
dog
hutyr
cdna
adjunct
therapi
cmm
demonstr
signifi
cant
increas
surviv
time
compar
control
group
none
dog
develop
system
advers
reaction
toxic
seen
overal
safeti
dna
vaccin
confi
rmed
vaccin
develop
repres
tremend
mileston
dna
scienc
technolog
viru
west
nile
viru
wnv
mosquitoborn
member
famili
flavivirida
genu
flaviviru
fi
rst
identifi
ed
uganda
africa
positivesens
singlestrand
rna
viru
ssrna
kb
encod
singl
polyprotein
seven
nonstructur
protein
three
structur
protein
rna
strand
held
within
nucleocapsid
wnv
replic
cytoplasm
infect
cell
wnv
zoonot
viru
primari
reservoir
bird
signifi
cant
impact
spread
infect
across
countri
contin
differ
speci
describ
carrier
viru
wnv
spread
bird
bird
mosquito
bite
take
blood
meal
bird
infect
viru
bird
speci
get
ill
die
other
clinic
sign
surviv
mosquito
also
capabl
spread
viru
hors
dog
cat
mice
allig
lot
mammal
also
human
onethird
hors
bitten
carrier
mosquito
develop
diseas
die
affect
euthanasia
requir
incub
period
rang
day
hors
becom
ill
vari
symptom
muscl
trembl
skin
twitch
ataxia
sleepi
dull
listless
wnv
may
cross
placenta
mother
gestat
foal
hors
spread
diseas
human
wnv
produc
differ
outcom
human
like
hors
fever
headach
chill
diaphoresi
weak
swollen
lymph
node
drowsi
pain
joint
compar
symptom
infl
uenza
sever
neuroinvas
infect
includ
mening
enceph
wnvdna
vaccin
surfac
envelop
protein
e
main
target
antibodi
respons
copi
e
protein
matur
wnv
virion
e
function
interact
cell
surfac
fusion
viru
cellular
membran
premembran
protein
prm
cleav
viral
matur
smaller
membran
peptid
express
prm
e
protein
cell
result
format
viruslik
particl
vlp
vlp
share
mani
antigen
structur
properti
fulli
matur
virus
special
interest
vaccin
develop
fig
fi
nal
express
plasmid
immun
hors
contain
human
cytomegaloviru
earli
gene
promot
signal
sequenc
japanes
viru
fusion
gene
part
fi
shing
industri
aquacultur
also
known
aqua
farm
contrast
commerci
fi
shing
harvest
wild
fi
sh
aquacultur
involv
cultiv
freshwat
saltwat
fi
sh
popul
shrimp
oyster
control
condit
salmon
one
main
foodproduc
fi
sh
world
dna
vaccin
fi
sh
must
safe
anim
especi
safe
fi
sh
consum
salmon
major
econom
contributor
world
product
farm
fi
sh
repres
u
billion
annual
unit
state
salmon
farm
also
big
norway
scotland
canada
chile
sourc
salmon
consum
unit
state
europ
like
anim
also
fi
sh
threaten
virus
bacteria
parasit
one
major
problem
salmon
infecti
hematopoiet
necrosi
ihn
viru
viru
infecti
hematopoiet
necrosi
ihn
viru
common
viral
pathogen
wild
farm
salmonid
particular
pacifi
c
salmonid
rainbow
trout
atlant
salmon
ihn
viru
enzoot
pacifi
c
northwest
howev
vari
effect
differ
pacifi
c
salmonid
negativesens
singlestrand
ssrna
viru
member
rhabdovirida
famili
genu
novirhabdoviru
rna
genom
nucleotid
long
contain
leader
l
trailer
sequenc
respect
code
region
n
p
g
nv
l
gene
g
encod
surfac
glycoprotein
socal
spike
main
target
immun
respons
transmiss
ihnv
transmit
follow
shed
viru
fece
urin
sexual
fl
uid
extern
mucu
direct
contact
close
contact
surround
contamin
water
viru
gain
entri
fi
sh
base
fi
ns
salmon
carnivor
current
fed
meal
produc
catch
wild
fi
sh
marin
organ
perman
origin
possibl
infect
ihnv
clinic
sign
infect
ihnv
includ
anemia
skin
darken
bulg
eye
fade
gill
abdomin
distens
infect
fi
sh
commonli
hemorrhag
sever
area
like
mouth
pector
fi
ns
muscl
near
anu
yolk
sac
fri
diseas
fi
sh
weaken
eventu
fl
oat
surfac
water
necrosi
common
kidney
spleen
sometim
liver
mortal
rate
older
fi
sh
kg
tend
rang
smolt
mortal
rate
often
exce
averag
cumul
mortal
follow
outbreak
estim
ihnvdna
vaccin
antigen
viral
surfac
glycoprotein
g
capabl
elicit
neutral
antibodi
product
protect
immun
respons
g
gene
clone
eukaryot
express
vector
insert
intermediateearli
promot
polyadenyl
signal
special
vaccin
prepar
twocompon
vaccin
singl
vaccin
one
plasmid
second
compon
portion
nucleic
acid
sequenc
encod
second
peptid
deriv
fi
sh
pathogen
said
rhabdoviru
result
fusion
second
pathogen
fi
sh
pathogen
eg
isav
ipnv
iridoviru
nnv
spdv
svcv
vhsv
koi
herp
viru
rational
behind
presenc
ihnv
g
protein
boost
immun
respons
second
protein
result
protect
effect
infect
fi
sh
pathogen
vaccin
given
intramuscularli
dosag
left
dorsal
fl
ank
area
dorsal
fi
n
fi
rst
dna
fi
sh
vaccin
licens
canada
veterinari
biolog
section
vb
anim
health
product
divis
canadian
food
inspect
agenc
cfia
also
use
studi
norway
mani
environment
stressor
diseas
infl
uenc
serious
threat
life
european
honey
bee
api
mellifera
european
honey
bee
profession
manag
worldwid
honey
product
pollin
bee
import
unit
state
year
ago
fi
rst
european
settler
call
white
man
fl
nativ
american
indian
first
report
unit
state
mysteri
socal
coloni
collaps
disord
ccd
decim
bee
coloni
fi
rst
observ
winter
without
interrupt
similar
situat
also
given
europ
bee
live
coloni
fi
rst
descript
origin
earli
nineteenth
centuri
coloni
loss
known
england
isl
wight
diseas
american
call
phenomenon
disappear
diseas
wherea
coloni
loss
franc
late
call
mysteri
bee
loss
bee
gone
econom
valu
huge
loss
honey
bee
pollin
dramat
impact
agricultur
pollin
crop
nut
fruit
veget
pollin
mellifera
overal
valu
billion
unit
state
billion
eu
bee
coloni
produc
lb
honey
per
day
return
bee
pollin
million
fl
ower
one
keep
mind
besid
european
honey
bee
wild
insect
among
speci
wild
bee
also
great
impact
pollin
seem
effi
cient
pollin
manag
honey
bee
industri
farm
threaten
also
natur
biotop
wild
insect
pollin
ecolog
valu
total
global
econom
valu
honey
bee
pollin
calcul
billion
billion
food
agricultur
organ
fao
unit
nation
estim
million
manag
honey
bee
coloni
worldwid
besid
profession
agricultur
honey
bee
irreplac
biodivers
organ
appear
evolut
fi
rst
fl
ower
plant
exist
sinc
million
year
describ
chap
fig
swine
cattl
bee
europ
north
america
third
import
farm
anim
sinc
formal
list
farm
anim
switzerland
therefor
ccd
econom
also
essenti
global
ecolog
problem
urgent
must
solv
futur
bee
honey
caus
ccd
coloni
collaps
disord
last
year
seem
differ
past
outbreak
worker
bee
disappear
instead
die
place
leav
behind
queen
young
bee
high
level
bacteria
virus
fungi
measur
gut
remain
bee
collaps
occur
within
day
complex
problem
differ
theori
discuss
caus
ccd
pesticid
contamin
hotli
debat
interfer
nerv
system
affect
forag
behavior
bee
lead
abandon
hive
fungal
diseas
nosema
spp
known
big
bee
loss
spain
monocultur
genemanipul
crop
electro
smoke
radio
wave
caus
cell
phone
destroy
bee
compass
rigor
travel
truck
crop
crop
usa
februari
profession
us
beekeep
travel
coloni
countri
decemb
therebi
bee
must
reloc
time
europ
bee
coloni
begin
winter
sleep
around
septemb
also
climat
chang
temperatur
sensit
discuss
impact
crop
pollin
ccd
like
caus
combin
factor
varroa
destructor
ccd
case
overload
bloodsuck
varroa
mite
detect
varroa
current
consid
major
threat
apicultur
infect
diseas
call
varroosi
varroa
destructor
ectoparasit
reddishbrown
fl
shape
mm
long
mm
wide
eight
leg
v
destructor
infest
worker
bee
drone
brood
mite
develop
insid
brood
cell
varroa
real
colossu
compar
size
bee
seen
fig
varroa
mite
belong
scientifi
c
class
arachnida
subclass
acari
speci
describ
alon
mite
mite
prefer
carbohydr
food
meal
crop
hous
dust
mite
feed
fl
ake
shed
human
skin
varroa
mite
prefer
fresh
blood
hemolymph
bee
feed
lb
within
h
varroa
transport
hive
via
piggyback
worker
bee
femal
mite
enter
broad
cell
preferenti
drone
cell
cell
cap
varroa
lay
egg
larva
develop
egg
insect
take
day
bee
larva
mite
hatch
time
newborn
varroa
mite
spread
bee
lifetim
summer
mite
week
wherea
fall
mite
live
sever
month
varroa
reproduc
honey
bee
thu
consid
harmless
insect
varroa
diseas
global
pest
devast
effect
bee
fig
varroa
vector
varroa
may
consid
isol
agent
diseas
mortal
adult
bee
brood
must
consid
context
secondari
viral
infect
least
variou
virus
abl
infect
honey
bee
mostli
ssrna
virus
eight
virus
known
associ
varroa
mite
acut
bee
paralysi
viru
abpv
black
queen
cell
viru
bqcv
chronic
bee
paralysi
viru
cbpv
deform
wing
viru
dwv
kashmir
bee
viru
kbv
sacbrood
bee
viru
sbv
cloudi
wing
viru
cwv
slow
bee
paralysi
viru
sbpv
varroa
control
number
natur
synthet
chemic
commerci
avail
control
varroa
infest
fi
rst
compound
bromopropyl
fl
uvalin
pyrethroid
insecticid
make
long
stori
short
varroa
mite
becam
resist
one
product
given
chemic
class
resist
entir
class
sever
relat
synthet
product
also
use
natur
product
formic
acid
miner
oil
thymol
partial
tempor
effect
show
advers
effect
success
chemic
treatment
mite
quickli
develop
resist
chemic
immun
system
insect
basic
differ
insect
vertebr
immun
miss
highli
specifi
c
antigen
respons
acquir
immun
system
insect
nevertheless
million
year
evolut
insect
develop
power
defens
strategi
bacteria
fungi
virus
parasit
protect
primit
immun
system
insect
success
colon
terrestri
ecosystem
insect
innat
immun
show
mani
similar
vertebr
human
innat
immun
multifacet
involv
humor
cellular
compon
insight
insect
immun
provid
drosophila
melanogast
research
key
mechan
also
observ
honey
bee
humor
system
respons
bacteri
fungal
infect
control
antimicrobi
peptid
amp
circul
receptor
sens
danger
signal
activ
toll
pathway
wherea
membranebound
receptor
activ
imd
pathway
pathway
lead
transloc
nfkblike
transcript
factor
product
amp
nfkb
respons
element
detect
promot
region
diptericin
gene
cellular
immun
respons
mediat
special
blood
cell
hemocyt
plasmatocyt
crystal
cell
lamellocyt
plasmatocyt
repres
major
hemocyt
express
phagocyt
receptor
patrol
bodi
clear
microorgan
cell
b
c
debri
signal
infect
fat
bodi
bee
genom
complet
sequenc
bee
dna
vaccin
express
plasmid
construct
cmv
promot
surprisingli
bee
insect
specifi
c
promot
essenti
drive
express
protein
enhanc
green
fl
uoresc
protein
egfp
chosen
report
gene
insert
multipl
clone
site
togeth
enhanc
element
plasmid
construct
produc
e
coli
highli
purifi
ed
standard
techniqu
european
honey
bee
api
mellifera
obtain
local
beekeep
cultiv
lab
condit
varroa
mite
collect
infest
bee
oral
vaccin
egfp
plasmid
oper
feed
bee
mix
solut
sugar
plasmid
dna
vaccin
sugar
standard
sugar
solut
made
beekeep
normal
food
winter
bee
result
day
onset
feed
measur
express
egfp
immunofl
uoresc
western
blot
analysi
egfp
antibodi
day
clear
egfp
signal
detect
thorax
especi
malpighian
tubul
control
bee
fed
dna
lack
report
show
signal
parallel
control
experi
transform
e
coli
done
studi
possibl
egfp
express
gut
bacteria
instead
bee
cell
egfp
signal
detect
transform
bacteria
surprisingli
found
egfp
signal
day
varroa
mite
suck
hemolymph
bee
fed
vaccin
sugar
solut
signal
control
mite
infest
control
bee
feed
plasmid
dna
result
express
report
gene
differ
bee
tissu
period
sever
day
fi
nalli
varroa
absorb
protein
via
bloodsuck
bee
blood
carri
arteri
vein
fl
ow
loos
around
bodi
egfp
signal
detect
either
honey
stomach
fece
figur
illustr
egfp
passag
bee
bodi
toward
varroa
mite
start
simpl
idea
biochemistri
eukaryot
cell
remain
irrespect
organ
differ
given
confi
gurat
immun
system
mean
insect
success
fi
ght
parasit
infect
differ
weapon
cell
b
cell
consequ
antibodi
memori
abl
stimul
target
immun
gene
bee
measur
insect
typic
immun
respons
standard
plasmid
dna
vaccin
fi
rst
develop
hors
bridg
evolut
fi
sh
insect
mammal
vaccin
type
abl
job
fascin
biolog
protein
subunit
base
singl
protein
molecul
abl
stimul
humor
immun
respons
usual
cellular
respons
phagocytosi
protein
degrad
aciddepend
proteas
endosom
endosom
exogen
pathway
result
mhc
ii
present
antigen
peptid
peptid
one
form
subunit
carbohydr
also
use
subunit
poor
agedepend
immunogen
carbohydr
antigen
induc
cellindepend
b
cell
respons
discuss
chap
therefor
carbohydr
mainli
link
protein
conjug
enhanc
toe
immun
reaction
discuss
hib
conjug
vaccin
conjug
vaccin
polyribosylribitol
phosphat
prp
capsul
haemophilu
infl
uenza
type
b
hib
major
virul
factor
organ
prp
cellindepend
antigen
character
eg
induct
poor
antibodi
respons
less
infant
children
inabl
induc
booster
respons
polysaccharid
vaccin
base
prp
alon
develop
coval
linkag
prp
cell
depend
protein
antigen
conjug
vaccin
creat
overcom
cell
independ
characterist
prp
present
three
differ
licens
protein
carrier
link
prp
hboc
diphtheria
crm
protein
mutant
corynebacterium
linkag
spacer
hbomp
outer
membran
protein
omp
neisseria
meningitidi
linkag
spacer
prpd
diphtheria
toxoid
linkag
spacer
hib
conjug
vaccin
differ
protein
carrier
polysaccharid
size
method
chemic
conjug
includ
use
spacer
prp
protein
carrier
standard
chemic
conjug
polysaccharid
protein
illustr
fig
subunit
vaccin
offer
greater
safeti
intrins
poorli
immunogen
strong
adjuv
essenti
boost
activ
immun
respons
serotyp
variabl
dictat
modifi
cation
oantigen
portion
lp
antigen
vari
number
oligosaccharid
unit
repeat
type
distribut
carbohydr
intraand
intermolecular
linkag
fl
exneri
gene
encod
bacteri
chromosom
contrast
sonnei
show
serotyp
variabl
express
plasmidencod
oantigen
modifi
cation
enzym
antigen
one
major
immunogen
compon
shigella
virul
factor
part
due
mask
exposur
type
three
secret
apparatu
inclus
conserv
protein
vaccin
compound
potenti
solv
issu
serotyp
specifi
citi
thu
allow
gener
highli
desir
panshigella
vaccin
addit
recombin
protein
usual
increas
safeti
profi
le
anoth
import
impact
shigella
epidemiolog
prompt
vaccin
develop
increas
frequenc
antibioticresist
strain
antibiot
resist
continu
rise
pathogen
shigella
spp
caus
agent
shigellosi
first
defi
ned
caus
agent
bacillari
dysenteri
shiga
japan
shigella
gramneg
bacillu
noncapsul
nonmotil
diagnosi
gener
base
symptom
sinc
bloodi
mucoid
stool
indic
shigella
infect
howev
sever
diarrheal
infect
caus
microorgan
share
symptom
enteroinvas
e
coli
campylobact
among
other
sole
analysi
symptom
insuffi
cient
accur
diagnosi
therefor
clinic
diagnosi
must
complement
microbiolog
isol
cultur
shigella
invas
pathogenesi
shigella
transmit
fecalor
rout
consumpt
contamin
food
water
follow
ingest
acidtoler
shigella
pass
stomach
small
intestin
larg
intestin
fig
taken
cell
transcytos
basolater
face
colon
epithelium
present
resid
macrophag
wherein
ipab
type
three
secret
system
induc
apoptosi
caspas
activ
therebi
escap
kill
macrophag
shigella
invad
epitheli
cell
use
creat
transloc
pore
host
cell
membran
initi
orchestr
fl
ow
effector
host
cell
cytoplasm
induc
actin
rearrang
ultim
result
uptak
bacteria
insid
shigella
quickli
escap
vacuol
replic
move
cytoplasm
via
actinbas
motil
manner
shigella
form
protrus
neighbor
uninfect
cell
result
vacuol
quickli
lyse
complet
process
intercellular
spread
gene
associ
encod
plasmid
highli
conserv
among
shigella
speci
heart
type
three
secret
apparatu
compos
basal
bodi
similar
fl
agellar
system
extracellular
needl
invas
plasmid
antigen
ipad
kda
protein
form
pentamer
ring
tip
needl
control
secret
effector
protein
environment
sensor
mobil
ipab
tip
complex
ipab
kda
transloc
form
ring
atop
ipad
ring
respons
host
cell
contact
contact
requir
mobil
ipac
needl
tip
format
complet
unidirect
conduit
bacteri
cytoplasm
host
cell
cytoplasm
initi
infl
ammat
invas
process
occur
exclus
basolater
side
host
cell
highlight
import
previou
step
macrophag
subvers
shigella
colon
gut
anim
model
shigellosi
strictli
human
diseas
basi
restrict
unknown
complic
abil
investig
pathogenesi
shigella
howev
sever
anim
model
develop
studi
pathogenesi
shigella
result
immun
respons
shigella
antigen
protect
efficaci
candid
vaccin
shigellosi
nonhuman
primat
nhp
model
nhp
model
use
defi
ne
abil
vaccin
elicit
immun
respons
protect
rhesu
cynomolgu
monkey
main
advantag
model
shigella
abl
colon
larg
intestin
gener
symptom
bacteria
gener
human
infect
antigenproteosom
antigen
repres
variabl
portion
shigella
lp
fig
administr
lp
antigen
alon
anim
model
enough
elicit
immun
respons
make
ineffect
immunogen
solv
limit
molecul
use
conjunct
differ
protein
carrier
sever
variant
lpsoantigen
mixtur
develop
character
one
protein
combin
approach
use
fl
exneri
sonnei
lp
complex
neisseria
meningitidi
outer
membran
protein
proteosom
lp
extract
fl
exneri
sonnei
hot
phenol
extract
mix
detergentextract
outer
membran
protein
n
meningitidi
complex
separ
free
lp
present
mixtur
gel
fi
ltration
chromatographi
concept
behind
vaccin
protein
present
n
meningitidi
proteosom
abl
act
carrier
cell
stimul
thu
allow
recognit
lp
shigella
outer
membran
vesicl
outer
membran
vesicl
omv
particl
compos
lp
protein
nucleic
acid
propos
vaccin
formul
particl
purifi
ed
liquid
cultur
boydii
centrifug
subsequ
fi
ltere
fig
precis
ident
amount
protein
includ
prepar
current
known
although
presenc
protein
mass
ipab
ipac
ipad
suggest
composit
includ
protein
omv
administ
oral
mice
antibodi
gener
omv
lysat
vaccin
advantag
heterolog
protect
shown
challeng
strain
shigella
serogroup
absenc
adjuv
depend
addit
immun
passiv
transfer
offspr
suggest
protect
mechan
involv
antibodi
rais
possibl
vaccin
use
infant
main
target
popul
shigella
vaccin
use
live
fulli
virul
shigella
formul
process
presenc
lp
lottolot
consist
possibl
downsid
prepar
invaplex
anoth
vaccin
candid
use
protein
lp
part
formul
invaplex
complex
obtain
aqueou
extract
follow
ion
exchang
chromatographi
fig
precis
composit
extract
complet
character
includ
lp
ipab
ipac
complex
abl
b
c
fig
depict
lpsoantigenbas
vaccin
lp
extract
shigella
fl
exneri
sonnei
admix
protein
prepar
n
meningitid
use
carrier
complex
administ
oral
intranas
mice
guinea
pig
serum
igg
mucos
iga
intestin
lung
vaccin
compound
b
antigen
purifi
ed
lp
deliv
combin
exoprotein
p
aeruginosa
c
final
antigen
differ
shigella
serogroup
combin
ribosom
shigella
depict
elicit
igg
iga
respons
ipa
protein
well
lp
mice
guinea
pig
addit
protect
shigella
speciesserotyp
use
extract
gener
mous
guinea
pig
challeng
model
two
phase
one
studi
perform
use
invaplex
vaccin
adult
volunt
show
major
side
effect
deliveri
intranas
dose
highest
dose
employ
studi
gener
asc
respons
lp
volunt
advantag
approach
invaplex
addit
adjuv
need
administ
drawback
vaccin
consist
challeng
product
process
includ
cultur
virul
shigella
well
presenc
bacteri
lp
product
intermedi
step
fi
nal
formul
anoth
possibl
caveat
uniform
protein
composit
complex
manufactur
lot
final
vaccin
design
protect
multipl
serotyp
solut
possibl
drawback
howev
gener
formul
includ
invaplex
complex
gener
one
particular
serotyp
increas
alreadi
diffi
cult
manufactur
process
would
allow
gener
vaccin
formul
specifi
c
serotyp
preval
particular
region
vaccin
candid
target
conserv
shigella
virul
protein
includ
ipa
protein
fig
recombin
ipab
ipad
express
e
coli
high
level
ipad
easili
purifi
ed
e
coli
cytosol
ipab
must
purifi
ed
complex
cognat
chaperon
ipgc
chaperon
need
maintain
hydrophob
ipab
solubl
state
provid
stabil
ipab
proteolyt
degrad
ipab
purifi
ed
separ
ipgc
low
concentr
deterg
analys
indic
ipab
greater
pure
follow
scheme
fi
nal
formul
ipabas
vaccin
also
contain
doubl
mutant
heatlabil
enterotoxin
e
coli
dmlt
adjuv
mechan
protect
vaccin
yet
work
nevertheless
test
mous
lethal
pulmonari
model
exhibit
homolog
protect
fl
exneri
greater
heterolog
protect
use
sonnei
challeng
experi
igg
mucos
iga
gener
intranas
administr
along
antigenspecifi
c
cell
ompa
outer
membran
protein
omp
purifi
ed
fl
exneri
use
ion
exchang
chromatographi
incub
macrophag
protein
induc
product
nitric
oxid
increas
product
protein
deliv
parenter
fi
time
rabbit
give
protect
challeng
fl
exneri
rabbit
cecal
ligat
model
subsequ
work
use
recombin
protein
purifi
ed
affi
niti
chromatographi
identifi
ed
omp
ompa
part
famili
immunomodul
protein
present
numer
gramneg
bacteria
protein
show
high
protect
effi
caci
mous
lethal
pulmonari
model
elicit
serum
igg
mucos
iga
tick
wide
distribut
throughout
world
affect
world
cattl
popul
econom
import
tick
tickborn
diseas
tbd
estim
number
studi
howev
like
repres
underestim
real
impact
arthropod
vector
transmit
diseas
tick
feed
devast
effect
includ
diseas
transmiss
paralysi
toxicosi
secondari
infect
tickfeed
site
effect
tick
tickborn
diseas
particularli
pronounc
livestock
sector
repeatedli
rate
highli
impact
livelihood
farmer
particularli
countri
south
heavili
depend
agricultur
product
six
genera
ixodid
tick
import
name
amblyomma
dermacentor
haemaphysali
hyalomma
rhipicephalu
ixod
histor
tick
tickborn
diseas
control
focus
control
tick
toler
level
acaricid
use
treatment
diseas
appropri
drug
case
acaricidebas
tick
control
often
method
reduc
tick
popul
without
sacrifi
cing
product
acaricid
commerci
avail
number
formul
appli
either
directli
onto
livestock
dip
vat
multipl
anim
pass
regular
time
interv
acaricid
applic
reli
heavili
correct
formul
administr
effect
larg
number
chemic
compound
found
effect
tick
includ
arsen
introduc
ddt
cyclodien
toxaphen
organophosphatescarbam
group
formamid
macrocycl
lacton
potenc
use
mani
abovement
compound
gradual
erod
resist
develop
mani
tick
speci
rhipicephalu
amblyomma
hyalomma
multipl
acaricideresist
tick
stock
identifi
ed
limit
entir
exclud
use
mani
acaricid
addit
resist
chemic
control
guid
principl
antitick
vaccin
stem
earli
studi
conduct
acquir
host
resist
tick
infest
repeat
exposur
host
tick
tick
organ
homogen
induc
resist
tick
reinfest
degre
resist
may
vari
differ
tick
host
speci
evid
strongli
suggest
natur
resist
tick
infest
develop
base
adapt
immun
respons
mechan
tick
feed
host
vaccin
tick
compon
take
effector
molecul
feed
mediat
deleteri
effect
tick
effect
manifest
reduct
feed
time
tick
mortal
feed
reduc
engorg
weight
reduc
reproduct
capac
adult
femal
egg
laid
tick
fed
vaccin
host
may
also
show
reduc
hatch
rate
overal
result
culmin
reduct
tick
popul
tickborn
diseas
mani
antitick
vaccin
target
identifi
ed
use
convent
immunescreen
techniqu
immun
vertebr
host
tick
homogen
purifi
ed
tick
extract
gener
immun
sera
sera
use
screen
tick
antigen
detect
host
identifi
cation
tick
protein
essenti
tick
surviv
use
method
target
antigen
discoveri
made
increasingli
possibl
inform
gather
tick
biolog
avail
genom
sequenc
number
tick
speci
number
candid
discoveri
expand
revers
vaccinolog
use
techniqu
rna
interfer
rnai
use
confi
rming
import
antitick
vaccin
candid
like
play
role
futur
antitick
vaccin
antigen
discoveri
expos
conceal
antigen
antitick
vaccin
candid
classifi
ed
two
categori
expos
conceal
antigen
expos
antigen
secret
tick
saliva
attach
feed
host
conceal
antigen
normal
hidden
host
immun
respons
molecular
mimicri
tick
host
compon
observ
vaccin
may
induc
host
sensit
autoimmun
reaction
expos
antigen
use
one
advantag
use
expos
antigen
natur
boost
occur
tick
feed
mechanist
vaccin
expos
antigen
thought
induc
focal
hostil
environ
unsupport
tick
attach
feed
conceal
antigen
come
contact
host
immun
respons
natur
tick
feed
although
often
contain
within
thorac
caviti
tick
salivari
gland
protein
character
conceal
secret
tickfeed
site
one
diffi
culti
develop
conceal
antitick
vaccin
antigen
must
access
induc
humor
vaccin
respons
often
limit
number
candid
come
prolong
direct
contact
blood
meal
humor
respons
transport
gut
barrier
hemolymph
second
limit
conceal
antigen
relat
natur
boost
immun
respons
antigen
come
contact
immun
respons
within
host
suffi
cientli
high
antibodi
level
must
induc
repeat
vaccin
blood
meal
act
carrier
effector
immun
respons
antitick
effect
take
place
longer
period
time
compar
expos
antigen
effect
may
even
extend
beyond
mere
feed
period
inact
stage
digest
moltingegg
lay
take
place
antitick
vaccin
antitick
vaccin
remain
antitick
vaccin
commerci
produc
becom
benchmark
futur
antitick
vaccin
develop
evalu
gutassoci
glycoprotein
fi
rst
identifi
ed
r
microplu
although
homologu
tick
speci
sinc
identifi
ed
biolog
function
remain
unknown
although
thought
play
role
digest
blood
meal
r
microplu
express
increas
embryogenesi
reach
highest
level
unf
larva
express
decreas
feed
molt
lowest
level
express
detect
rest
stage
tick
translat
code
sequenc
amino
acid
size
kda
protein
contain
four
potenti
nlink
glycosyl
site
leader
peptid
suggest
transport
cell
surfac
local
studi
shown
molecul
locat
predominantli
microvilli
gut
epitheli
cell
singl
ctermin
transmembran
sequenc
present
unprocess
protein
replac
glycosylphosphatidylinositol
anchor
matur
protein
protein
also
contain
multipl
predict
egf
repeat
rich
cystein
residu
vaccin
perform
mostli
whole
molecul
protect
epitop
well
determin
site
protect
b
cell
epitop
defi
ned
addit
epitop
like
exist
overlap
crossreact
immunereact
epitop
found
r
decoloratu
homologu
vaccin
effi
caci
directli
relat
antibodi
titer
abil
control
tick
popul
directli
relat
achiev
strong
antibodi
respons
substanti
animaltoanim
variat
observ
abil
gener
antibodi
titer
like
relat
mhc
class
ii
haplotyp
express
antibodi
cattl
complement
system
taken
blood
meal
antibodi
bind
result
lysi
gut
epitheli
cell
culmin
impair
blood
meal
digest
strong
antibodi
respons
may
induc
tick
mortal
due
blood
leakag
gut
hemolymph
tick
may
turn
reddish
instead
gray
develop
antibodi
respons
cattl
immun
demonstr
fig
recombin
express
attempt
sever
express
system
includ
escherichia
coli
aspergillu
nidulan
aspergillu
niger
pichia
pastori
vaccin
trial
show
vaccin
target
mainli
adult
stage
r
microplu
particularli
number
adult
femal
fulli
engorg
postengorg
mortal
reproduct
capac
adult
r
microplu
femal
affect
term
egglay
capac
hatch
egg
fi
eld
situat
vaccin
cattl
reduc
tick
number
within
singl
gener
reduc
reproduct
capac
revers
neg
effect
tick
feed
live
weight
vaccin
anim
averag
increas
live
weight
kg
period
observ
extens
fi
eld
trial
cuba
brazil
argentina
mexico
show
control
r
microplu
tick
within
period
importantli
complet
control
acaricideresist
tick
could
accomplish
integr
vaccin
acaricid
use
show
integr
control
system
effect
control
tick
popul
vaccin
also
decreas
amount
acaricid
requir
control
tick
popul
prolong
time
interv
cattl
dip
vaccin
extens
evalu
abil
control
tick
speci
almost
complet
crossprotect
rhipicephalu
annulatu
report
signifi
cant
protect
hyalomma
anatolicum
h
dromedarii
r
decoloratu
observ
howev
crossprotect
seen
r
appendiculatu
amblyomma
variegatum
genet
attenu
microorgan
virus
bacteria
engin
deliv
recombin
heterolog
antigen
stimul
host
immun
system
experiment
vector
system
summar
work
vector
classifi
ed
requir
biosafeti
program
approv
work
vector
classifi
ed
higher
requir
approv
local
biosafeti
committe
safeti
concern
demonstr
adenoviru
follow
im
inject
vector
persist
mainli
near
inject
site
drain
lymph
node
month
low
level
integr
chromosom
dna
observ
calcul
mutat
rate
mutat
per
cell
spontan
mutat
rate
cell
therefor
tenfold
higher
classifi
ed
biosafeti
level
live
vector
abl
stimul
mucos
well
system
humor
cellular
immun
sever
drawback
vector
technolog
use
vector
effect
use
patient
recogn
antibodi
repeat
booster
immun
fail
also
preexist
immun
patient
vector
could
render
vaccin
ineffect
heterolog
primeboost
vector
prime
describ
chap
could
circumv
barrier
diseas
lactic
acid
bacteria
gener
recogn
safe
gra
statu
develop
past
decad
potent
adjuv
mucos
deliveri
vaccin
platform
technolog
base
lactobacillu
plantarum
fig
develop
deliv
antigen
plagu
diseas
caus
yersinia
pesti
aerob
nonmotil
gramneg
bacillu
belong
famili
enterobacteriacea
transmit
human
via
fl
eabit
via
aerosol
droplet
caus
bubon
pneumon
plagu
respect
human
plagu
case
present
one
three
primari
form
bubon
septicem
pneumon
secondari
plagu
septicemia
pneumonia
mening
common
complic
pathogen
pesti
result
impress
abil
overcom
defens
mammalian
host
overwhelm
massiv
growth
plagu
enzoot
rodent
africa
asia
south
america
north
america
pesti
transmit
host
host
fl
ea
via
blood
feed
consumpt
handl
infecti
host
tissu
inhal
infecti
materi
pesti
infect
astonishingli
broad
rang
mammal
use
rat
squirrel
mice
prairi
dog
marmot
gerbil
reservoir
sever
arthropod
vector
transmiss
fig
human
acquir
zoonot
infect
via
atyp
bite
anim
fl
ea
sometim
prompt
anim
death
plagu
fl
ea
seek
new
sourc
blood
infect
fl
ea
come
domest
black
rat
rattu
rattu
brown
sewer
rat
rattu
norvegicu
pesti
cell
spread
site
infect
fl
eabit
region
lymph
node
grow
high
number
caus
format
bubo
spill
bloodstream
bacteria
remov
liver
spleen
growth
continu
organ
spread
other
caus
septicemia
flea
feed
septicem
anim
complet
infect
cycl
human
bubon
plagu
develop
infect
lung
secondari
pneumon
plagu
lead
aerosol
transmiss
primari
pneumon
plagu
multipl
antibioticresist
strain
pesti
occur
natur
easili
bioengin
thu
plagu
categori
bioterror
agent
need
novel
strategi
prevent
bubon
plagu
classic
form
diseas
patient
usual
develop
symptom
fever
headach
chill
swollen
extrem
tender
lymph
node
bubo
within
day
contact
organ
either
fl
eabit
exposur
open
wound
infect
materi
primari
septicem
plagu
gener
defi
ned
occur
patient
posit
blood
cultur
palpabl
lymphadenopathi
patient
febril
chill
headach
malais
gastrointestin
disturb
primari
pneumon
plagu
rare
deadli
form
diseas
spread
via
respiratori
droplet
close
contact
ft
infect
individu
progress
rapidli
febril
fl
ulik
ill
overwhelm
pneumonia
cough
product
bloodi
sputum
incub
period
primari
pneumon
plagu
day
gener
patient
develop
secondari
plagu
pneumonia
high
fatal
rate
fig
schemat
plagu
cycl
small
mammal
host
fl
ea
vector
arrow
repres
connect
affect
climat
color
code
depend
infl
uential
climat
variabl
link
ie
precipit
temperatur
variabl
indirectli
depend
soil
characterist
soil
moistur
grey
rectangl
somewhat
arbitrarili
delimit
epizoot
enzoot
zoonot
cycl
note
despit
locat
far
end
cycl
human
often
provid
avail
inform
plagu
dynam
laboratori
diagnosi
plagu
base
bacteriolog
andor
serolog
evid
sampl
analysi
includ
blood
bubo
aspir
sputum
cerebrospin
fl
uid
patient
plagu
mening
scrape
skin
lesion
present
stain
techniqu
gram
giemsa
wright
wayson
stain
provid
support
presumpt
confi
rmatori
evid
plagu
infect
lactic
acid
bacteria
lab
group
gramposit
nonpathogen
nonsporul
bacteria
includ
speci
lactobacillu
fig
lactococcu
leuconostoc
pediococcu
streptococcu
limit
biosynthet
abil
requir
preform
amino
acid
b
vitamin
purin
pyrimidin
sugar
carbon
energi
sourc
nutrit
requir
restrict
habitat
requir
compound
abund
thu
highli
special
bacteria
occupi
rang
nich
includ
milk
plant
surfac
oral
caviti
gastrointestin
tract
vagina
vertebr
lab
consum
centuri
human
ferment
food
extraordinari
safeti
profi
le
intrins
advantag
turn
lab
excel
deliveri
vector
novel
prevent
therapeut
molecul
human
number
studi
oral
vaccin
gener
genet
engin
pathogen
commens
bacteria
report
live
attenu
pathogen
bacteria
deriv
mycobacterium
salmonella
bordetella
spp
popular
live
deliveri
vector
use
current
particularli
well
adapt
interact
mucos
surfac
special
machineri
initi
infect
process
major
disadvantag
live
vaccin
includ
inadequ
attenu
potenti
revert
virul
lactic
acid
bacteriabas
vaccin
act
live
attenu
vaccin
without
safeti
concern
lab
gener
recogn
safe
gra
statu
thu
like
caus
harm
product
desir
antigen
lab
occur
three
differ
cellular
locat
intracellular
allow
protein
escap
harsh
extern
environment
condit
gastric
juic
stomach
requir
cellular
lysi
protein
releas
deliveri
extracellular
allow
releas
protein
extern
medium
result
direct
interact
environ
food
product
digest
tract
cell
wall
anchor
combin
advantag
two
locat
ie
interact
cell
wallanchor
protein
environ
addit
protect
proteolyt
degrad
context
sever
studi
compar
product
differ
antigen
lab
use
three
locat
evalu
subsequ
immunolog
impact
studi
demonstr
highest
immun
respons
obtain
cell
wallanchor
antigen
expos
surfac
lab
therefor
recent
lab
vaccin
studi
select
surfac
exposur
antigen
interest
rather
intraor
extracellular
product
dendrit
cell
dc
play
central
role
bridg
innat
immun
system
adapt
immun
system
dc
found
throughout
bodi
especi
common
mucos
surfac
singl
layer
epitheli
cell
separ
extern
intern
world
amid
constant
need
particl
exchang
intestin
dendrit
cell
dc
play
key
role
maintain
intestin
homeostasi
well
govern
protect
immun
respons
invad
pathogen
avoid
activ
selfreact
cell
limit
unnecessari
respons
commens
fl
ora
dc
imprint
toler
onto
cell
fig
immaturetyp
dc
enrich
underneath
epithelium
mucos
induct
site
pois
captur
antigen
extend
protrus
epitheli
cell
enabl
direct
sampl
lumin
antigen
upregul
mhc
costimulatori
molecul
matur
dc
convert
highli
effi
cient
antigenpres
cell
success
antigen
present
cell
requir
recognit
cognat
peptid
context
mhc
class
ii
molecul
wherea
epitop
present
mhc
class
molecul
stimul
agspecifi
c
cell
antigen
uptak
occur
dc
chang
phenotyp
express
higher
level
costimulatori
molecul
move
cell
area
induct
site
antigen
present
thu
dc
deriv
cytokin
play
key
role
induct
antigenspecifi
c
effector
th
cell
respons
regard
target
mucos
dc
effect
strategi
induc
mucos
system
immun
respons
lab
persist
abil
lab
persist
gastrointestin
tract
may
critic
import
effect
labbas
vaccin
comparison
persist
lab
strain
l
plantarum
nonpersist
lab
strain
l
lacti
identifi
ed
l
plantarum
effect
elicit
antigenspecifi
c
immun
suggest
persist
promot
immunogen
furthermor
shown
particular
lactobacillu
speci
induc
critic
infl
ammatori
cytokin
induc
activ
matur
dendrit
cell
also
shown
immatur
dc
effi
cientli
captur
lactobacillu
speci
bacteria
activ
human
dc
result
product
proinfl
ammatori
cytokin
like
increas
prolifer
cell
skew
cell
respons
toward
pathway
believ
involv
effect
clearanc
microbi
pathogen
fig
evid
suggest
peptidoglycan
layer
lab
promot
natur
immunoadjuvant
antigen
local
cell
wall
make
access
immun
system
compar
intracellular
secret
protein
leader
peptid
mark
protein
transloc
across
cytoplasm
membran
lipid
modifi
cation
major
import
anchor
export
protein
membran
protein
function
shown
lipid
fi
rst
amino
acid
matur
borrelia
burgdorferi
ospa
protein
essenti
induc
immun
respons
via
leader
peptid
ospa
target
protein
cell
envelop
lactobacillu
cy
recogn
l
plantarum
cell
wallsort
machineri
lipid
anchor
protein
cell
envelop
end
result
deliveri
system
exert
potent
adjuv
effect
viruslik
particl
vlp
mimic
antigen
architectur
authent
virion
howev
produc
insect
mammalian
plant
cell
express
capsid
protein
particul
natur
highdens
present
viral
structur
protein
surfac
render
vlp
premier
vaccin
platform
superior
safeti
immunogen
manufactur
therefor
chapter
focus
develop
effect
nov
vaccin
base
vlp
capsid
protein
express
structur
nov
vlp
especi
vlp
norwalk
viru
prototyp
nov
extens
discuss
abil
nov
vlp
stimul
potent
system
mucos
antinov
immun
oral
intranas
deliveri
mice
present
gastroenter
ge
worldwid
health
problem
affect
peopl
age
name
impli
ge
character
infl
ammat
gastrointestin
tract
often
associ
symptom
diarrhea
nausea
vomit
abdomin
cramp
pain
ge
associ
diarrheal
diseas
remain
one
top
caus
death
world
especi
develop
countri
young
children
estim
death
toll
four
six
million
per
year
ge
caus
varieti
pathogen
includ
virus
bacteria
parasit
ingest
noninfecti
toxin
medic
virus
common
offend
agent
noroviru
nov
rotaviru
common
virus
caus
viral
ge
adenoviru
astroviru
coronaviru
parechoviru
also
known
caus
ge
human
nov
group
genet
divers
rna
virus
belong
genu
noroviru
calicivirida
famili
fi
rst
discov
character
prototyp
viru
norwalk
viru
nv
studi
nv
reveal
nov
nonenvelop
virus
rna
genom
surround
round
capsid
protein
shell
approxim
nm
diamet
nov
divid
genogroup
cluster
cluster
genogroup
gi
gii
giii
giv
gv
within
fi
genotyp
gi
giv
strain
found
infect
human
exclus
gii
found
human
pig
giii
gv
strain
anim
virus
infect
cattl
murin
speci
respect
current
strain
cluster
gii
gii
preval
nov
human
popul
genom
nov
fi
rst
character
nv
contain
singlestrand
positivesens
rna
kb
three
open
read
frame
orf
poli
tail
end
fig
encod
polyprotein
process
viral
proteas
rnadepend
rna
polymeras
approxim
fi
nonstructur
protein
includ
nucleosid
triphosphatas
vpg
two
structur
protein
major
minor
capsid
protein
encod
respect
structur
analysi
nov
reveal
viral
capsid
compos
dimer
icosahedr
symmetri
fold
two
domain
shell
domain
respons
initi
capsid
assembl
icosahedr
contact
protrud
domain
p
contain
two
subdomain
enhanc
stabil
capsid
provid
intermolecular
contact
dimer
studi
nv
also
indic
protein
enhanc
express
level
stabil
viral
capsid
nov
highli
contagi
spread
rapidli
outbreak
commonli
occur
variou
social
place
set
peopl
share
common
food
water
sourc
close
physic
proxim
cruis
ship
school
militari
unit
nurs
home
daycar
center
hospit
restaur
cater
event
life
cycl
nov
fulli
understood
due
lack
vitro
cell
cultur
system
small
anim
model
infect
failur
nov
replic
mammalian
cell
cultur
due
lack
host
factor
support
intracellular
express
nov
rna
instead
problem
may
lie
step
viral
bind
cellular
receptor
viru
entri
cell
nov
serum
antibodi
nov
readili
detect
method
littl
clinic
relev
due
crossreact
antibodi
sinc
cultur
system
avail
nov
detect
viru
stool
sampl
becom
prefer
method
diagnosi
tradit
nov
infect
diagnos
detect
viru
immun
transmiss
electron
microscopi
tem
tem
offer
advantag
direct
visual
potenti
respons
viru
particl
stool
sampl
howev
disadvantag
requir
sophist
expens
equip
highli
special
technician
oper
sever
enzymelink
immunosorb
assay
elisa
detect
nov
antigen
later
develop
nov
diagnosi
studi
shown
nov
antigendetect
elisa
high
specifi
citi
poor
sensit
like
due
antigen
divers
nov
strain
similar
elisabas
assay
rtpcr
rapid
robust
process
larg
number
sampl
simultan
result
obtain
within
work
day
howev
requir
rna
extract
fecal
sampl
need
expens
equip
skill
worker
oper
therefor
rtpcr
labor
intens
less
econom
elisa
overal
tem
elisa
rtpcrbase
method
advantag
challeng
three
method
detect
differ
compon
viru
therefor
complementari
immunolog
nov
infect
immunolog
knowledg
nov
mostli
obtain
human
challeng
studi
natur
outbreak
due
lack
small
anim
model
observ
repeat
infect
adult
suggest
scarciti
longterm
immun
virus
howev
studi
show
close
genet
suscept
subject
infect
nov
challeng
support
possibl
longterm
immun
nov
lack
tissu
cultur
system
also
imped
develop
vaccin
nov
fortun
discoveri
spontan
assembl
express
viruslik
particl
vlp
morpholog
antigen
similar
nativ
virus
facilit
vaccin
develop
vlp
combin
best
trait
wholeviru
subunit
antigen
vaccin
develop
vlp
noninfecti
therefor
safer
inactiv
attenu
viru
due
lack
viral
nucleic
acid
genom
importantli
vlp
induc
potent
cellular
humor
immun
respons
without
adjuv
effect
vaccin
subunit
antigen
architectur
mimic
infecti
virus
vlp
produc
recombin
technolog
heterolog
express
system
without
requir
abil
support
viral
replic
particularli
import
nov
cultur
system
develop
support
growth
virus
studi
demonstr
virus
correspond
vlp
particl
size
ideal
dc
macrophag
uptak
initi
antigen
process
thu
particul
natur
vlp
favor
target
relev
apc
optim
induct
cellmedi
immun
respons
vlp
also
present
effi
cientli
b
cell
induc
strong
antibodi
respons
like
live
virus
quasicrystallin
surfac
vlp
array
repetit
epitop
present
prime
target
vertebr
b
cell
evolv
specifi
calli
recogn
recognit
trigger
crosslink
surfac
membraneassoci
immunoglobulin
ig
b
cell
lead
prolifer
migrat
helpercel
activ
antibodi
product
secret
gener
memori
b
cell
thu
vlp
directli
activ
b
cell
much
lower
concentr
subunit
antigen
induc
high
titer
durabl
b
cell
respons
absenc
adjuv
inher
advantag
vlp
made
one
success
recombin
vaccin
platform
exampl
fi
vlpbase
vaccin
hepat
b
viru
character
nov
vlp
vlp
nov
fi
rst
produc
insect
cell
use
baculoviru
vector
plant
use
tobamoviru
geminiviru
vector
mammalian
cell
use
venezuelan
equin
enceph
vee
replicon
system
studi
demonstr
express
major
capsid
protein
alon
drive
selfassembl
vlp
morpholog
antigen
resembl
nativ
viru
particl
fig
vlp
gener
three
express
system
similar
structur
nov
vlp
exemplifi
ed
vlp
nv
capsid
protein
nvcp
studi
insect
cellbaculovirusderiv
nvcp
vlp
cryoelectron
microscopi
xray
crystallographi
reveal
nv
capsid
nm
icosahedr
arrang
copi
kda
capsid
protein
organ
dimer
symmetri
dimer
form
two
ident
nvcp
monom
two
differ
dimer
confi
gurat
requir
correctli
form
complet
assembl
capsid
nativ
nv
particl
nvcp
also
fold
two
distinct
domain
vlp
domain
form
inner
core
shell
p
domain
protrud
capsid
similarli
subdomain
also
surfaceexpos
region
nv
vlp
may
contain
hbga
neutral
antibodybind
site
determin
strain
specifi
citi
similar
vlp
nv
nov
includ
virus
demonstr
insect
cellbaculoviru
vectorproduc
nvcp
vlp
shown
four
oral
dose
littl
nvcp
vlp
without
adjuv
trigger
serum
nvspecifi
c
antiigg
respons
major
vlpfed
outbr
mice
system
igg
respons
observ
two
oral
dosag
highest
titer
induc
four
dose
vlp
moreov
mice
dosag
group
develop
nvspecifi
c
intestin
iga
level
total
iga
inclus
mucos
adjuv
cholera
toxin
ct
signifi
cantli
chang
number
posit
respond
serum
igg
intestin
iga
signifi
cantli
enhanc
amplitud
serum
igg
respons
especi
higher
dose
vlp
thu
nvcp
vlp
clearli
potent
oral
immunogen
induc
system
gut
mucos
antibodi
respons
nanovaccin
ga
infect
group
streptococcu
streptococcu
pyogen
ga
import
human
mucos
pathogen
respons
wide
spectrum
diseas
vari
clinic
manifest
sever
pharyng
strep
throat
common
minor
complic
ga
infect
left
untreat
lead
lifethreaten
diseas
includ
autoimmun
sequela
rheumat
fever
rf
rheumat
heart
diseas
rhd
rhd
result
perman
damag
heart
tissu
valv
ga
infect
caus
death
year
mostli
develop
countri
indigen
popul
within
develop
nation
poor
socioeconom
condit
overcrowd
contribut
high
rate
ga
diseas
develop
countri
rf
lead
caus
heart
diseas
among
children
current
avail
vaccin
prevent
infect
ga
consequ
prevent
ga
diseas
success
mucos
ga
vaccin
would
need
stimul
appropri
humor
cellular
immun
protect
ga
infect
fig
especi
diffi
cult
due
lack
humancompat
mucos
vaccin
adjuv
essenti
boost
immun
respons
research
therefor
focus
mainli
parenter
ga
vaccin
deliveri
approach
suitabl
adjuv
avail
design
provid
protect
system
infect
via
induct
opson
igg
antibodi
antigen
effect
ga
vaccin
need
broad
antigen
reach
mani
differ
ga
strain
differ
type
circul
popul
fig
ga
vaccin
approach
ga
breach
physic
barrier
mucos
epithelium
nasalassoci
lymphoid
tissu
function
analog
human
tonsil
purport
transport
underli
lymphoid
tissu
via
associ
membran
cell
cell
innat
immun
system
sens
ga
produc
cytokin
chemokin
contain
infect
mucosa
ga
antigen
deliv
antigenpres
cell
dc
b
cell
igacommit
b
cell
activ
initi
antigenspecifi
c
iga
respons
dc
play
fundament
role
develop
immun
ga
present
antigen
cell
induc
respons
integr
along
iga
mucos
defens
pharyng
ga
colon
mucos
vaccin
design
mimic
respons
effect
clear
ga
mucos
surfac
upon
infect
prevent
ga
colon
carriag
ga
escap
host
defens
mechan
dissemin
lymphat
blood
lead
system
infect
mucos
vaccin
also
abl
induc
system
immun
respons
character
induct
opson
igg
antibodi
destroy
pathogen
opsonophagocytosi
parenter
ga
vaccin
induc
serum
igg
abl
induc
mucos
immun
induc
immun
respons
potenti
crossreact
self
tissu
protein
ga
protein
major
protect
antigen
ideal
target
vaccin
develop
howev
contain
heart
tissu
crossreact
epitop
particularli
conserv
region
evid
suggest
crossreact
cell
especi
play
pivot
role
pathogenesi
rhd
protein
coiledcoil
surfac
protein
consist
hypervari
aminotermin
region
highli
conserv
sequenc
ident
carboxytermin
crepeat
region
fig
function
protein
import
prevent
bacteri
clearanc
complementmedi
phagocytosi
limit
host
defens
mechan
previou
studi
indic
protect
immun
ga
evok
opson
antibodi
serotyp
epitop
aminotermin
region
mtype
specifi
c
nanovaccin
combin
vaccineadjuv
deliveri
system
offer
potenti
mucos
vaccin
deliveri
exampl
lipidcorepeptid
lcp
system
novel
synthet
selfadjuv
vaccin
deliveri
system
incorpor
adjuv
prr
agonist
carrier
antigen
peptid
vaccin
singl
molecular
entiti
fig
system
previous
shown
effi
cientli
deliv
ga
vaccin
induc
immun
evid
suggest
adjuv
activ
lcp
involv
induct
dc
activ
preclin
develop
three
approach
current
investig
develop
subunit
ga
vaccin
base
protein
multival
ga
vaccin
multival
approach
employ
combin
aminotermin
protein
fragment
repres
differ
type
design
target
preval
ga
strain
popul
use
approach
recombin
multival
ga
vaccin
contain
protein
peptid
differ
ga
serotyp
preval
north
america
demonstr
evok
opson
antibodi
anim
epidemiolog
data
vaccin
would
cover
major
pharyng
invas
ga
diseas
includ
rf
invas
fasciiti
toxic
shock
syndrom
recent
new
ga
vaccin
shown
immunogen
rabbit
evok
opson
antibodi
nonvaccin
serotyp
potenti
creat
vaccin
much
broader
coverag
type
vaccin
popul
specifi
c
therefor
may
effect
univers
may
also
need
redesign
period
refl
ect
chang
epidemiolog
ga
infect
ch
ch
ch
ch
ch
fig
lipidcorepeptid
lcp
system
lcp
system
contain
adjuv
compon
lipidcor
made
lipoamino
acid
polylysin
carrier
onto
peptid
epitop
attach
exampl
show
ga
vaccin
candid
contain
aminotermin
serotyp
epitop
call
adjuv
three
n
lipoamino
acid
separ
glycin
amino
acid
spacer
vaccin
ga
vaccin
employ
peptid
epitop
conserv
crepeat
region
protein
second
approach
potenti
theori
greater
coverag
type
immun
mice
cregion
peptid
ga
vaccin
candid
call
conjug
carrier
protein
diphtheria
toxoid
dt
codeliveri
appropri
adjuv
led
protect
system
mucos
ga
infect
fig
also
elicit
protect
immun
ga
link
lipopeptid
studi
shown
intranas
immun
mice
cregion
peptid
conjug
experiment
mucos
adjuv
cholera
toxin
b
subunit
ctb
evok
protect
immun
ga
mucos
level
ctb
could
possibl
enter
olfactori
region
central
nervou
system
caus
neuron
damag
follow
intranas
deliveri
therefor
suitabl
human
use
vector
deliveri
approach
includ
express
crepeat
region
vaccinia
viru
commens
bacterium
lactococcu
lacti
streptococcu
gordonii
third
combin
vaccin
approach
use
serotyp
conserv
protein
peptid
epitop
initi
heteropolym
ga
vaccin
construct
synthes
free
radicalinduc
polymer
acryloyl
peptid
combin
seven
serotyp
epitop
highli
conserv
cregion
peptid
epitop
call
type
target
heteropolym
repres
ga
infect
preval
northern
territori
australia
region
highli
endem
ga
immun
mice
heteropolym
demonstr
excel
immunogen
protect
fig
preclin
evalu
ga
vaccin
candid
intranas
immun
mice
vaccin
candid
led
significantli
greater
surviv
intranas
challeng
ga
versu
control
group
mucos
adjuv
ctb
essenti
protect
multiepitop
lcpbase
ga
vaccin
candid
elicit
protect
immun
mucos
ga
infect
even
absenc
ctb
b
homolog
heterolog
ga
strain
indic
potenti
provid
broad
coverag
howev
batchtobatch
variat
led
alter
immun
respons
limit
applic
human
use
vaccin
also
requir
addit
adjuv
effect
limit
use
mucos
vaccin
due
lack
safe
effect
mucos
adjuv
later
multiepitop
ga
vaccin
candid
synthes
base
lcp
system
induc
highli
opson
antibodi
follow
parenter
deliveri
mice
well
protect
mucos
ga
infect
follow
intranas
immun
fig
safeti
effi
caci
main
concern
use
larg
region
protein
ga
vaccin
potenti
induc
autoimmun
respons
due
immunolog
crossreact
host
protein
therefor
import
identifi
protect
antigen
determin
separ
biolog
relev
epitop
host
tissu
crossreact
potenti
harm
epitop
map
studi
use
identifi
conserv
ga
vaccin
candid
contain
conform
protect
b
cell
epitop
design
lack
human
heart
crossreact
cell
epitop
